Human kallikrein 4
Subtitle: protein expression, enzymatic activity and association to cancer.
Published: 2005
Language: eng
Number of pages: 242
Description: KLK4 is a new member of human tissue kallikrein family of serine proteases. It has similarities to the prostate cancer (CaP) biomarker PSA, including prostate-restricted expression. We examined the clinical utility of the KLK4 protein (hK4) in cancer diagnostics, as well as its structure and enzymatic function in order to gain further understanding of its physiological and pathological roles. We employed recombinant protein technology to obtain active enzyme and immunogen for anti-hK4 antibody generation. Polyclonal and monoclonal antibodies were used to establish hK4-specific immunoassays, which were used to quantify hK4 in normal human tissues, biological fluids and benign/cancerous prostate samples. Immunohistochemistry, Western blotting and autoradiography were also used to assess hK4. On the mRNA level, KLK4 expression was assessed using RT-PCR in ovarian cancer. Profiling of enzymatic activity was performed using fluorogenic peptides, protein substrates and serine protease inhibitors. These studies led to the discovery of a novel KLK4 mRNA isoform and experimental evidence of its coding exon 1. Results show that KLK4 expression is an independent, unfavourable indicator of progression-free and overall survival in grade I and II ovarian carcinoma (P &lt; 0.001). Immunofluorometric investigations found highest hK4 levels in prostate tissues although at much lower levels relative to the amount of mRNA. hK4 levels in seminal plasma were also low in most samples (&lt;5 mug/L) though occasional samples had relatively high hK4 (100--280 mug/L). On the tissue level, hK4 was noted to be lower in benign prostatic hyperplasia (BPH) than in CaP (p = 0.02). However, hK4 did not show promise as biomarker in prostate cancer since serum hK4 levels were mostly below the detection limit, and recovery of hK4 from serum was low due to rapid complexing likely with alpha-2-macroglobulin. Enzymatic profiling of recombinant hK4 indicated trypsin-like activity with preferential cleavage after arginine over lysine. hK4 rapidly formed covalent complexes with the serpins alpha-1-antitrypsin and alpha-2-antiplasmin, cleaved the extracellular matrix proteins fibrinogen, collagen IV and to a limited extent, collagen I. Together with differential expression in BPH and CaP, overall results indicate possible involvement of hK4 in prostate cancer through its expression and enzymatic activity.
Notes: Thesis (Ph.D.)--University of Toronto, 2005.

Electronic version licensed for access by U. of T. users.

Source: Dissertation Abstracts International, Volume: 66-06, Section: B, page: 2966.